We are live on ! Find out more
REVH

Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock

Delisted

REVH was delisted on the 6th of December, 2022.

68 hedge funds and large institutions have $477M invested in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

13% more capital invested

Capital invested by funds: $421M → $477M (+$55.9M)

0% more funds holding

Funds holding: 6868 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

Holders
68
Holders Change
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
18
Reduced
9
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HF
51
HRT Financial
New York
$419K +$3.05K +312 +0.7%
DAM
52
DLD Asset Management
New York
$308K
Toronto Dominion Bank
53
Toronto Dominion Bank
Ontario, Canada
$299K +$6.54K +669 +2%
Geode Capital Management
54
Geode Capital Management
Massachusetts
$297K +$114K +11,702 +62%
RCM
55
Robinson Capital Management
Michigan
$263K
TI
56
Tidal Investments
Wisconsin
$262K
CSS
57
Cubist Systematic Strategies
Connecticut
$247K +$247K +25,274 New
FLC
58
Fifth Lane Capital
Texas
$244K
SSA
59
Schonfeld Strategic Advisors
New York
$168K +$15.3K +1,567 +10%
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
$140K +$140K +14,296 New
PCM
61
PenderFund Capital Management
British Columbia, Canada
$81K
PCM
62
Penserra Capital Management
California
$56K +$9.21K +942 +19%
LCM
63
Lynwood Capital Management
Ontario, Canada
$49K
UBS Group
64
UBS Group
Switzerland
$23K +$1.56K +160 +7%
CM
65
Cohanzick Management
New York
$4K
First Manhattan
66
First Manhattan
New York
$4K
MF
67
Magnetar Financial
Illinois
$3.89K -$1.33M -135,543 -25%
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$2.35K +$2.35M +239,955 New
FC
69
Finepoint Capital
Massachusetts
-$21.2M -2,163,205 Closed
SCC
70
Spring Creek Capital
Kansas
-$6.87M -699,780 Closed
JP Morgan Chase
71
JP Morgan Chase
New York
-$932K -95,000 Closed
TYCC
72
Texas Yale Capital Corp
Florida
-$196K -20,000 Closed
Jane Street
73
Jane Street
New York
-$128K -13,072 Closed
WRBC
74
W.R. Berkley Corp
Connecticut
-$96K -9,825 Closed
AA
75
Ancora Advisors
Ohio
-$69K -7,000 Closed

REVH Hedge Fund Activity: Q2 2022 in Review

68 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) for Q2 2022, worth a combined $477M — up 13% from $421M a quarter earlier.

Fund positioning in REVH was balanced in Q2 2022: 10 funds opened new positions, 10 closed out, 18 added to existing stakes and 9 trimmed.

The largest buyer was HGC Investment Management, adding an estimated $37.1M. The largest seller was Finepoint Capital, exiting entirely with an estimated $21.2M sold.

  • 68 institutional investors held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $477M of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock stock for Q2 2022, up 13% quarter-over-quarter.
  • 10 funds opened new Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock positions in Q2 2022 and 10 closed out, a net change of 0 holders.
  • The largest Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock buyer in Q2 2022 was HGC Investment Management, an estimated $37.1M added.
  • The largest Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock seller in Q2 2022 was Finepoint Capital, an estimated $21.2M sold.

Based on aggregated 13F filings for Q2 2022.